Hueso M - Search Results

1

Development of cationic solid lipid nanoparticles incorporating cholesteryl-9-carboxynonanoate (9CCN) for delivery of antagomiRs to macrophages.

Mallén A, Narváez-Narváez DA, Pujol MD, Navarro E, Maria Suñé-Negre J, García-Montoya E, Pérez-Lozano P, Torrejón-Escribano B, Suñé-Pou M, Hueso M. Mallén A, et al. Among authors: hueso m. Eur J Pharm Biopharm. 2024 Apr;197:114238. doi: 10.1016/j.ejpb.2024.114238. Epub 2024 Feb 27. Eur J Pharm Biopharm. 2024. PMID: 38417704 Free article.

2

ncRNAs in Therapeutics: Challenges and Limitations in Nucleic Acid-Based Drug Delivery.

Hueso M, Mallén A, Suñé-Pou M, Aran JM, Suñé-Negre JM, Navarro E. Hueso M, et al. Int J Mol Sci. 2021 Oct 27;22(21):11596. doi: 10.3390/ijms222111596. Int J Mol Sci. 2021. PMID: 34769025 Free PMC article. Review.

3

Editorial to the IJMS Special Issue on "ncRNAS in Therapeutics".

Hueso M, Navarro E. Hueso M, et al. Int J Mol Sci. 2023 Mar 29;24(7):6448. doi: 10.3390/ijms24076448. Int J Mol Sci. 2023. PMID: 37047420 Free PMC article.

4

Dynamic Variations of 3'UTR Length Reprogram the mRNA Regulatory Landscape.

Navarro E, Mallén A, Hueso M. Navarro E, et al. Among authors: hueso m. Biomedicines. 2021 Oct 28;9(11):1560. doi: 10.3390/biomedicines9111560. Biomedicines. 2021. PMID: 34829789 Free PMC article. Review.

5

Sex Differences in Glomerular Lesions, in Atherosclerosis Progression, and in the Response to Angiotensin-Converting Enzyme Inhibitors in the ApoE^-/- Mice Model.

Mallén A, Rodriguez-Urquia R, Alvarez R, Dorca-Duch E, Navarro E, Hueso M. Mallén A, et al. Among authors: hueso m. Int J Mol Sci. 2023 Aug 30;24(17):13442. doi: 10.3390/ijms241713442. Int J Mol Sci. 2023. PMID: 37686247 Free PMC article.

6

Unveiling ncRNA regulatory axes in atherosclerosis progression.

Navarro E, Mallén A, Cruzado JM, Torras J, Hueso M. Navarro E, et al. Among authors: hueso m. Clin Transl Med. 2020 Feb 3;9(1):5. doi: 10.1186/s40169-020-0256-3. Clin Transl Med. 2020. PMID: 32009226 Free PMC article. Review.

7

An Exonic Switch Regulates Differential Accession of microRNAs to the Cd34 Transcript in Atherosclerosis Progression.

Hueso M, Cruzado JM, Torras J, Navarro E. Hueso M, et al. Genes (Basel). 2019 Jan 21;10(1):70. doi: 10.3390/genes10010070. Genes (Basel). 2019. PMID: 30669689 Free PMC article.

8

The double edge of anti-CD40 siRNA therapy: It increases renal microcapillar density but favours the generation of an inflammatory milieu in the kidneys of ApoE ^-/- mice.

Hueso M, Casas A, Mallén A, de Ramón L, Bolaños N, Varela C, Cruzado JM, Torras J, Navarro E. Hueso M, et al. J Inflamm (Lond). 2019 Dec 16;16:25. doi: 10.1186/s12950-019-0228-9. eCollection 2019. J Inflamm (Lond). 2019. PMID: 31889910 Free PMC article.

9

Chronic Kidney Disease is associated with an increase of Intimal Dendritic cells in a comparative autopsy study.

Hueso M, Torras J, Carrera M, Vidal A, Navarro E, Grinyó J. Hueso M, et al. J Inflamm (Lond). 2015 Mar 29;12:26. doi: 10.1186/s12950-015-0073-4. eCollection 2015. J Inflamm (Lond). 2015. PMID: 25861247 Free PMC article.

10

Relationship between subclinical rejection and genotype, renal messenger RNA, and plasma protein transforming growth factor-beta1 levels.

Hueso M, Navarro E, Moreso F, Beltrán-Sastre V, Ventura F, Grinyó JM, Serón D. Hueso M, et al. Transplantation. 2006 May 27;81(10):1463-6. doi: 10.1097/01.tp.0000206102.67063.24. Transplantation. 2006. PMID: 16732186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page